Invention Grant
- Patent Title: Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
-
Application No.: US14045454Application Date: 2013-10-03
-
Publication No.: US09234040B2Publication Date: 2016-01-12
- Inventor: Gerard Zurawski , Jacques F. Banchereau , Eynav Klechevsky , Sandra Zurawski , Anne-Laure Flamar
- Applicant: Baylor Research Institute
- Applicant Address: US TX Dallas
- Assignee: Baylor Research Institute
- Current Assignee: Baylor Research Institute
- Current Assignee Address: US TX Dallas
- Agency: Norton Rose Fulbright US LLP
- Main IPC: A61K39/21
- IPC: A61K39/21 ; A61K39/145 ; A61K39/04 ; A61K39/39 ; A61K39/395 ; C07K16/28 ; A61K39/02 ; A61K39/12 ; A61K47/48 ; B82Y5/00 ; C12N5/0784 ; A61K39/00
Abstract:
The present invention includes compositions and methods for increasing the effectiveness of antigen presentation using a DCIR-specific antibody or fragment thereof to which an antigen is attached that forms an antibody-antigen complex, wherein the antigen is processed and presented by a dendritic cell that has been contacted with the antibody-antigen complex.
Public/Granted literature
- US20140134168A1 VACCINES BASED ON TARGETING ANTIGEN TO DCIR EXPRESSED ON ANTIGEN-PRESENTING CELLS Public/Granted day:2014-05-15
Information query
